Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Partial acute transverse myelitis is a predictor of multiple sclerosis in children.
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis.
[The process of meaning-making in adjustment to multiple sclerosis.]
Emotional and neutral verbal memory impairment in Multiple Sclerosis.
Mitochondrial complex I gene variations; as a potential genetic risk factor in pathogenesis of multiple sclerosis.
Utility of Disease-Specific Measures and Clinical Balance Tests in Prediction of Falls in Persons With Multiple Sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations.
Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Multiple sclerosis presenting as a relapsing amnestic syndrome.
Acute transverse myelitis after thoracic epidural anesthesia and analgesia: Should anesthesia and analgesia be blamed?
Outcomes after Percutaneous Surgery for Patients with Multiple Sclerosis Related Trigeminal Neuralgia.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
"Disease modifying nutricals" for multiple sclerosis.
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
RORs in Autoimmune Disease.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
Pages
« first
‹ previous
…
321
322
323
324
325
326
327
328
329
…
next ›
last »